Please login to the form below

Not currently logged in
Email:
Password:

International Rare Disease Day

Today sees the fourth International Rare Disease Day, organised by the European Organisation for Rare Diseases

Today (February 28) sees the fourth International Rare Disease Day, an annual campaign organised by the European Organisation for Rare Diseases (EURORDIS) to raise awareness of life-threatening and debilitating diseases that affect a comparatively small percentage of the population.

This year's campaign focuses on health inequalities, with EURORDIS highlighting such issues as a lack of medical experts and knowledge about rare diseases, as well as a comparatively limited amount of care and research.

There are thought to be between 5,000 and 8,000 rare diseases worldwide, with more than 60 million people in Europe and the US affected alone.

Yann Le Cam, CEO, EURORDIS, explained some of the issues people with rare diseases face: “Many are fighting to obtain life-saving treatments or to be reimbursed by their health authorities. Others are denied access to specialised services and to disability compensation.”

Events for 2011 include a conference in Brussels organised with the European Commission to discuss health inequalities, with participants including Antonyia Parvanova, MEP, who is involved with the EU Directive on cross-border healthcare and patient mobility.

On February 28, EURORDIS is hosting a live stream of this European Symposium on rare diseases, with talks throughout the day until 4.45pm CET.

 EURORDIS' live stream of this European Symposium on rare diseases

28th February 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics